Congratulations to Dr. Kenneth Rosenfield

Dr. Rosenfield is a distinguished interventional cardiologist and visionary leader with over 35 years of dedication to patient care and the advancement of cardiovascular disease treatment across the globe. He is widely recognized for his seminal work in endovascular therapy, pioneering innovative techniques and devices and spearheading well-known initiatives that have left a lasting impact on the field. A dedicated educator and mentor, Dr. Rosenfield continues to shape the future of vascular medicine and inspire colleagues and trainees across disciplines internationally.

Specializing in complex cardiac and vascular interventions, he is a leader in treating carotid, kidney, and peripheral artery disease, as well as complex venous thromboembolic diseases. Since 2002, Dr. Rosenfield has been a leading faculty member at the Massachusetts General Hospital (MGH), where he is the former Director of Invasive Cardiology. Currently, he is Section Head for Vascular Medicine and Intervention, chairs the Acute Myocardial Infarction (STEMI) Committee, and maintains a faculty appointment at Harvard Medical School.

Dr. Rosenfield has contributed significantly to the field’s body of knowledge and approach to care. His contributions have led to practice changing findings including some of the earliest studies of intravascular ultrasound to understand vascular pathology, the development of self-expanding stents and drug coated balloons, the treatment of carotid stenosis, and the catheter based and team-based management of critical limb ischemia and pulmonary embolism. Most recently, he originated the concept of the Pulmonary Embolism Response Team (PERT) and implemented it with colleagues at MGH. He founded The National PERT Consortium™, a nonprofit designed to improve the management and outcomes of patients with PE. PERT has transformed the paradigm of care and now comprises physicians and health care professionals from all major medical institutions, engages in cutting-edge clinical trials, manages a research database, certifies hospital centers of excellence, and organizes a large annual international meeting on PE. In each of these domains of vascular medicine and interventional cardiology, Dr. Rosenfield has designed and served as international principal investigator for numerous landmark clinical trials, authoring 300+ peer-reviewed journal publications.

Dr. Rosenfield’s accolades reflect his remarkable career. In recognition of his extraordinary contributions, the PERT Consortium™ established the Dr. Kenneth Rosenfield Founder's Award and Keynote Lectureship. He also received the American Heart Association Laennec Master Clinician Award. He has held leadership roles as President of the Society for Cardiovascular Angiography & Interventions (SCAI) and the Massachusetts Chapter of the American College of Cardiology (ACC) where he also served on its Board of Governors. In addition, he is a founder and former board member of VIVA Physicians.

Dr. Rosenfield completed two fellowships: in interventional cardiology/vascular medicine at St. Elizabeth’s Medical Center in Boston, and in cardiovascular medicine at New England Medical Center (now Tufts Medical Center). He did his residency, including a Chief Resident year, at Kaiser San Francisco Medical Center. He earned his MD from the University of Massachusetts Medical School. He later got a Master of Science in health care delivery science from Dartmouth, from where he also graduated cum laude with a Bachelor of Arts in psychology.